{"id":17558,"date":"2026-06-21T18:10:44","date_gmt":"2026-06-21T16:10:44","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/"},"modified":"2026-06-21T18:10:45","modified_gmt":"2026-06-21T16:10:45","slug":"le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/","title":{"rendered":"Le d\u00e9pistage ne r\u00e9duit pas la mortalit\u00e9 due au m\u00e9lanome cutan\u00e9"},"content":{"rendered":"<p><!--$--><\/p>\n<div data-hk=\"0000a104212000a22200\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<p>\u00c0 partir de 35 ans, l&rsquo;assurance maladie l\u00e9gale prend en charge un examen cutan\u00e9 pr\u00e9ventif tous les deux ans. Le contr\u00f4le cutan\u00e9 vise \u00e0 d\u00e9tecter plus t\u00f4t le cancer de la peau noire et \u00e0 sauver des vies. Mais une nouvelle \u00e9valuation remet en question ce b\u00e9n\u00e9fice : l&rsquo;Allemagne ne fait pas mieux en mati\u00e8re de mortalit\u00e9 par m\u00e9lanome que les pays voisins qui ne disposent pas d&rsquo;un d\u00e9pistage complet du cancer de la peau.<\/p>\n<\/div>\n<div data-hk=\"0000a104212000a22210\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<p>L&rsquo;analyse OFFIS comprend des donn\u00e9es sur les d\u00e9c\u00e8s en Allemagne et dans neuf pays voisins de 2009 \u00e0 2022. Ces chiffres ne signifient pas que le contr\u00f4le cutan\u00e9 est inutile. Ils montrent cependant que l\u2019avantage esp\u00e9r\u00e9 n\u2019a pas encore \u00e9t\u00e9 prouv\u00e9 dans les donn\u00e9es sur les d\u00e9c\u00e8s.<\/p>\n<\/div>\n<aside data-hk=\"0000a104212000a222204\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-mobile Ad-Slot-hor Ad-Slot-FC\">\n<div class=\"Ad-Slot-FC-Container\">\n<div class=\"Ad-Slot-FC-Window\">\n<div id=\"ad-slot-mobile-hor-2\" data-orientation=\"hor\" data-index=\"2\" data-slot=\"ad-slot\" data-device=\"mobile\"><\/div>\n<\/div>\n<\/div>\n<\/aside>\n<div data-hk=\"0000a104212000a22230\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<h2>Le d\u00e9pistage du cancer de la peau ne r\u00e9duit pas actuellement la mortalit\u00e9<\/h2>\n<p>L&rsquo;Allemagne a introduit le d\u00e9pistage du cancer de la peau \u00e0 l&rsquo;\u00e9chelle de la population en 2008 &#8211; le seul exemple d&rsquo;un tel programme dans le monde \u00e0 ce jour. Les femmes et les hommes \u00e2g\u00e9s de 35 ans et plus y ont droit. L&rsquo;examen a lieu tous les deux ans et n&rsquo;est pas bas\u00e9 sur le risque individuel.<\/p>\n<\/div>\n<div data-hk=\"0000a104212000a22240\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<p>Les auteurs de l\u2019\u00e9tude sont partis d\u2019une simple consid\u00e9ration. Si le programme devait sauver de nombreuses vies, la mortalit\u00e9 due au cancer de la peau noire devrait \u00e9voluer plus favorablement que dans des pays comparables sans une pr\u00e9vention globale, mais cet effet ne pourrait pas \u00eatre observ\u00e9.<\/p>\n<\/div>\n<aside data-hk=\"0000a104212000a222504\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-mobile Ad-Slot-out\">\n<div id=\"ad-slot-mobile-out-1\" data-orientation=\"out\" data-index=\"1\" data-slot=\"ad-slot\" data-device=\"mobile\"><\/div>\n<\/aside>\n<div data-hk=\"0000a104212000a22260\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<p>Entre 2009 et 2022, la mortalit\u00e9 par m\u00e9lanome, standardis\u00e9e selon l\u2019\u00e2ge, a diminu\u00e9 dans toutes les r\u00e9gions examin\u00e9es. Toutefois, l\u2019Allemagne ne s\u2019en sort pas mieux. <\/p>\n<\/div>\n<div data-hk=\"0000a104212000a22270\" class=\"Ad-Row\">\n<div class=\"Ad-Col col-lg-5\">\n<div data-hk=\"0000a104212000a2227104\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-desktop Ad-Slot-ver\" role=\"region\" aria-label=\"Anzeige 1\">\n<div id=\"ad-slot-desktop-ver-1\" data-orientation=\"ver\" data-index=\"1\" data-slot=\"ad-slot\" data-device=\"desktop\"><\/div>\n<\/div>\n<\/div>\n<div class=\"Ad-Col col-lg-5\">\n<aside data-hk=\"0000a104212000a2227204\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-desktop Ad-Slot-ver Ad-Slot-FC\">\n<div class=\"Ad-Slot-FC-Container\">\n<div class=\"Ad-Slot-FC-Window\">\n<div id=\"ad-slot-desktop-ver-2\" data-orientation=\"ver\" data-index=\"2\" data-slot=\"ad-slot\" data-device=\"desktop\"><\/div>\n<\/div>\n<\/div>\n<\/aside>\n<\/div>\n<\/div>\n<div data-hk=\"0000a104212000a22280\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<ul>\n<li>La baisse annuelle moyenne \u00e9tait de 1,8 pour cent. <\/li>\n<li>Dans les neuf pays voisins, ce chiffre \u00e9tait de 2,2 pour cent. <\/li>\n<\/ul>\n<p>La diff\u00e9rence s\u2019est av\u00e9r\u00e9e non statistiquement significative.<\/p>\n<\/div>\n<div data-hk=\"0000a104212000a22290\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<h2>La comparaison des pays remplace les donn\u00e9es patientes incertaines<\/h2>\n<p>Des recherches ant\u00e9rieures comparaient souvent des personnes avec et sans d\u00e9pistage. Cependant, un probl\u00e8me pratique se posait : dans les donn\u00e9es de facturation disponibles, il \u00e9tait souvent impossible de distinguer avec certitude si une personne venait pour des soins pr\u00e9ventifs r\u00e9guliers ou si elle \u00e9tait examin\u00e9e en raison d&rsquo;un changement cutan\u00e9 d\u00e9j\u00e0 suspect.<\/p>\n<\/div>\n<aside data-hk=\"0000a104212000a222a1004\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-mobile Ad-Slot-hor\">\n<div id=\"ad-slot-mobile-hor-3\" data-orientation=\"hor\" data-index=\"3\" data-slot=\"ad-slot\" data-device=\"mobile\"><\/div>\n<\/aside>\n<div data-hk=\"0000a104212000a222a110\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<p>La pr\u00e9sente \u00e9tude a donc choisi une approche diff\u00e9rente. Au lieu de comparer des personnes individuelles, les scientifiques ont compar\u00e9 l\u2019Allemagne avec neuf pays voisins sans d\u00e9pistage du cancer de la peau \u00e0 l\u2019\u00e9chelle de la population. Cependant, le professeur priv\u00e9 Joachim H\u00fcbner, l&rsquo;un des auteurs de l&rsquo;\u00e9tude, d\u00e9clare : \u00ab\u00a0Les \u00e9tudes pr\u00e9c\u00e9dentes n&rsquo;ont montr\u00e9 aucun b\u00e9n\u00e9fice clair du d\u00e9pistage. Cependant, les d\u00e9fis m\u00e9thodologiques d&rsquo;une telle preuve ne doivent pas \u00eatre sous-estim\u00e9s.\u00a0\u00bb<\/p>\n<\/div>\n<aside data-hk=\"0000a104212000a222a1204\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-mobile Ad-Slot-hor\">\n<div id=\"ad-slot-mobile-hor-4\" data-orientation=\"hor\" data-index=\"4\" data-slot=\"ad-slot\" data-device=\"mobile\"><\/div>\n<\/aside>\n<div data-hk=\"0000a104212000a222a130\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<h2>Donn\u00e9es de 79,1 millions de personnes en Allemagne<\/h2>\n<p>Bien que des millions de personnes aient droit au test, le taux de participation estim\u00e9 d\u2019ici deux ans n\u2019est que d\u2019environ 32 pour cent.<\/p>\n<\/div>\n<div data-hk=\"0000a104212000a222a140\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<p>Pour l&rsquo;analyse, les scientifiques ont examin\u00e9 les donn\u00e9es d&rsquo;une moyenne de 79,1 millions de personnes en Allemagne et de 164,8 millions d&rsquo;habitants des pays de comparaison. Le Schleswig-Holstein a \u00e9t\u00e9 laiss\u00e9 de c\u00f4t\u00e9. Un projet pilote y avait d\u00e9j\u00e0 eu lieu en 2003 et 2004, ce qui aurait pu influencer les r\u00e9sultats \u00e0 long terme.<\/p>\n<\/div>\n<aside data-hk=\"0000a104212000a222a1504\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-mobile Ad-Slot-hor\">\n<div id=\"ad-slot-mobile-hor-5\" data-orientation=\"hor\" data-index=\"5\" data-slot=\"ad-slot\" data-device=\"mobile\"><\/div>\n<\/aside>\n<aside data-hk=\"0000a104212000a222a1604\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-desktop Ad-Slot-hor Ad-Slot-FC\">\n<div class=\"Ad-Slot-FC-Container\">\n<div class=\"Ad-Slot-FC-Window\">\n<div id=\"ad-slot-desktop-hor-2\" data-orientation=\"hor\" data-index=\"2\" data-slot=\"ad-slot\" data-device=\"desktop\"><\/div>\n<\/div>\n<\/div>\n<\/aside>\n<div data-hk=\"0000a104212000a222a170\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<p>H\u00fcbner tire donc une conclusion sobre. \u00ab\u00a0Le r\u00e9sultat est d\u00e9cevant\u00a0\u00bb, d\u00e9clare le chef du Centre d&rsquo;\u00e9valuation clinique de l&rsquo;\u00c9tat de Basse-Saxe.<\/p>\n<\/div>\n<div data-hk=\"0000a104212000a222a180\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<h2>Plusieurs causes sont remises en question<\/h2>\n<p>Il n&rsquo;est pas possible de d\u00e9terminer avec certitude \u00e0 partir des donn\u00e9es pourquoi l&rsquo;Allemagne n&rsquo;obtient pas d&rsquo;avantage mesurable malgr\u00e9 son offre de soins particuli\u00e8re. Les auteurs \u00e9voquent cependant plusieurs explications possibles. Cela comprend\u00a0:<\/p>\n<\/div>\n<div data-hk=\"0000a104212000a222a190\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<ul>\n<li>La qualit\u00e9 de l&rsquo;examen peut varier dans la pratique quotidienne.<\/li>\n<li>Les personnes pr\u00e9sentant un risque particuli\u00e8rement \u00e9lev\u00e9 pourraient \u00eatre moins susceptibles d\u2019accepter cette offre.<\/li>\n<li>Des m\u00e9dicaments am\u00e9lior\u00e9s contre le m\u00e9lanome avanc\u00e9 du cancer de la peau pourraient avoir r\u00e9duit la mortalit\u00e9 dans de nombreux pays en m\u00eame temps.<\/li>\n<\/ul>\n<p>Alexander Katalinic de l&rsquo;Universit\u00e9 de L\u00fcbeck, \u00e9galement auteur de l&rsquo;\u00e9tude, estime qu&rsquo;un autre point est important :<\/p>\n<\/div>\n<aside data-hk=\"0000a104212000a222a2004\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-mobile Ad-Slot-hor\">\n<div id=\"ad-slot-mobile-hor-6\" data-orientation=\"hor\" data-index=\"6\" data-slot=\"ad-slot\" data-device=\"mobile\"><\/div>\n<\/aside>\n<div data-hk=\"0000a104212000a222a210\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<blockquote>\n<p>Il est \u00e9galement possible que l\u2019offre de d\u00e9pistage n\u2019atteigne pas les personnes qui pourraient en b\u00e9n\u00e9ficier le plus.<\/p>\n<\/blockquote>\n<\/div>\n<div data-hk=\"0000a104212000a222a220\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<p>Si la majorit\u00e9 des personnes \u00e0 faible risque y participent, le succ\u00e8s sera in\u00e9vitablement limit\u00e9.<\/p>\n<\/div>\n<div data-hk=\"0000a104212000a222a230\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<h2>Les chercheurs restent prudents<\/h2>\n<p>Les auteurs soulignent express\u00e9ment que leur \u00e9tude pr\u00e9sente des limites. Les pays diff\u00e8rent en mati\u00e8re de soins m\u00e9dicaux et d\u2019utilisation de nouvelles th\u00e9rapies. H\u00fcbner d\u00e9clare donc : \u00ab Bien entendu, notre \u00e9tude n\u2019est pas exempte de sources d\u2019erreur possibles. \u00bb<\/p>\n<\/div>\n<aside data-hk=\"0000a104212000a222a2404\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-mobile Ad-Slot-hor\">\n<div id=\"ad-slot-mobile-hor-7\" data-orientation=\"hor\" data-index=\"7\" data-slot=\"ad-slot\" data-device=\"mobile\"><\/div>\n<\/aside>\n<aside data-hk=\"0000a104212000a222a2504\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-desktop Ad-Slot-out\">\n<div id=\"ad-slot-desktop-out-1\" data-orientation=\"out\" data-index=\"1\" data-slot=\"ad-slot\" data-device=\"desktop\"><\/div>\n<\/aside>\n<div data-hk=\"0000a104212000a222a260\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<p>Selon les scientifiques, des analyses suppl\u00e9mentaires ont \u00e9t\u00e9 r\u00e9alis\u00e9es pour prendre en compte au moins partiellement l&rsquo;influence de nouveaux m\u00e9dicaments contre le cancer m\u00e9tastatique de la peau noire. N\u00e9anmoins, on ne sait toujours pas pourquoi l\u2019Allemagne ne montre pas une \u00e9volution plus favorable malgr\u00e9 son programme.<\/p>\n<\/div>\n<div data-hk=\"0000a104212000a222a270\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<h2>La pr\u00e9vention peut aussi avoir des cons\u00e9quences ind\u00e9sirables<\/h2>\n<p>L&rsquo;\u00e9tude re\u00e7oit une actualit\u00e9 suppl\u00e9mentaire gr\u00e2ce au projet de loi sur la stabilisation du taux de cotisation \u00e0 l&rsquo;assurance maladie l\u00e9gale. Celui-ci pr\u00e9voit de revoir le d\u00e9pistage du cancer de la peau existant et de prendre \u00e9galement en compte une approche davantage bas\u00e9e sur les risques.<\/p>\n<\/div>\n<aside data-hk=\"0000a104212000a222a2804\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-mobile Ad-Slot-hor\">\n<div id=\"ad-slot-mobile-hor-8\" data-orientation=\"hor\" data-index=\"8\" data-slot=\"ad-slot\" data-device=\"mobile\"><\/div>\n<\/aside>\n<div data-hk=\"0000a104212000a222a290\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<p>Julia Beckhaus, du registre \u00e9pid\u00e9miologique du cancer de Basse-Saxe, souligne un autre aspect : \u00ab Il s&rsquo;agit d&rsquo;une utilisation optimale des ressources limit\u00e9es du syst\u00e8me de sant\u00e9. \u00bb Le temps n\u00e9cessaire aux examens pr\u00e9ventifs n\u2019est pas disponible pour d\u2019autres traitements.<\/p>\n<\/div>\n<div data-hk=\"0000a104212000a222a300\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<p>En outre, une d\u00e9tection pr\u00e9coce peut \u00e9galement pr\u00e9senter des inconv\u00e9nients. \u00abOn oublie aussi parfois que le d\u00e9pistage provoque \u00e9galement des dommages, par exemple une incertitude due \u00e0 des r\u00e9sultats de tests faussement positifs\u00bb, explique Beckhaus. \u00c0 cela s\u2019ajoute le surdiagnostic. Les m\u00e9decins d\u00e9couvrent des changements qui n\u2019auraient jamais provoqu\u00e9 de sympt\u00f4mes sans le d\u00e9pistage. N\u00e9anmoins, d\u2019autres examens ou traitements suivent souvent.<\/p>\n<\/div>\n<aside data-hk=\"0000a104212000a222a3104\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-mobile Ad-Slot-hor\">\n<div id=\"ad-slot-mobile-hor-9\" data-orientation=\"hor\" data-index=\"9\" data-slot=\"ad-slot\" data-device=\"mobile\"><\/div>\n<\/aside>\n<div data-hk=\"0000a104212000a222a320\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<p>Selon l\u2019\u00e9quipe de recherche, un d\u00e9pistage plus cibl\u00e9 du cancer de la peau pourrait apporter un plus grand b\u00e9n\u00e9fice aux personnes pr\u00e9sentant un risque accru \u00e0 l\u2019avenir tout en \u00e9vitant des fardeaux inutiles.<\/p>\n<\/div>\n<aside data-hk=\"0000a104212000a222a3304\" data-qa-ad-slot class=\"Ad-Slot Ad-Slot-desktop Ad-Slot-hor\">\n<div id=\"ad-slot-desktop-hor-3\" data-orientation=\"hor\" data-index=\"3\" data-slot=\"ad-slot\" data-device=\"desktop\"><\/div>\n<\/aside>\n<div data-hk=\"0000a104212000a222a340\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<h2>En r\u00e9sum\u00e9 :<\/h2>\n<ul>\n<li>Dans une vaste \u00e9tude comparative, le d\u00e9pistage du cancer de la peau en Allemagne n&rsquo;a pas pu montrer un net avantage en mati\u00e8re de r\u00e9duction de la mortalit\u00e9 due au cancer de la peau noire par rapport \u00e0 neuf pays voisins ne disposant pas d&rsquo;un programme complet.<\/li>\n<li>Entre 2009 et 2022, la mortalit\u00e9 par m\u00e9lanome a diminu\u00e9 dans tous les pays examin\u00e9s, mais la baisse en Allemagne, de 1,8 pour cent en moyenne par an, n&rsquo;a pas \u00e9t\u00e9 plus importante que dans les pays de comparaison.<\/li>\n<li>Les chercheurs pensent qu&rsquo;une approche plus cibl\u00e9e du d\u00e9pistage du cancer de la peau est envisageable, car un meilleur ciblage des personnes \u00e0 haut risque pourrait accro\u00eetre les b\u00e9n\u00e9fices tout en r\u00e9duisant les examens inutiles et les \u00e9ventuels surdiagnostics.<\/li>\n<\/ul>\n<p>Par Eva Schmitt<\/p>\n<\/div>\n<div data-hk=\"0000a104212000a222a350\" class=\"Html-Block\" data-qa-article-content-text data-text-milestone-block>\n<p><i>L\u2019original de cet article \u00ab Le d\u00e9pistage du cancer de la peau est cens\u00e9 sauver des vies \u2013 mais une nouvelle \u00e9tude soul\u00e8ve de s\u00e9rieux doutes \u00bb vient de Smart Up News.<\/i><\/p>\n<\/div>\n<p><!--\/--><br \/>\n<!--$--><br \/>\n<!--\/--><br \/>\n<!--$--><br \/>\n<!--\/--><br \/>\n<!--$--><br \/>\n<!--\/--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c0 partir de 35 ans, l&rsquo;assurance maladie l\u00e9gale prend en charge un examen cutan\u00e9 pr\u00e9ventif<\/p>\n","protected":false},"author":1,"featured_media":17559,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[2769,1002,3217,5615,820,359,658],"class_list":["post-17558","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-cutane","tag-depistage","tag-due","tag-melanome","tag-mortalite","tag-pas","tag-reduit","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Le d\u00e9pistage ne r\u00e9duit pas la mortalit\u00e9 due au m\u00e9lanome cutan\u00e9 - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le d\u00e9pistage ne r\u00e9duit pas la mortalit\u00e9 due au m\u00e9lanome cutan\u00e9 - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"\u00c0 partir de 35 ans, l&rsquo;assurance maladie l\u00e9gale prend en charge un examen cutan\u00e9 pr\u00e9ventif\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-21T16:10:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-21T16:10:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2026\/06\/Le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/6affb9c7fc596daaea315c8c28318135\"},\"headline\":\"Le d\u00e9pistage ne r\u00e9duit pas la mortalit\u00e9 due au m\u00e9lanome cutan\u00e9\",\"datePublished\":\"2026-06-21T16:10:44+00:00\",\"dateModified\":\"2026-06-21T16:10:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/\"},\"wordCount\":1282,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2026\/06\/Le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome.jpeg\",\"keywords\":[\"cutan\u00e9\",\"d\u00e9pistage\",\"due\",\"m\u00e9lanome\",\"mortalit\u00e9\",\"pas\",\"r\u00e9duit\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/\",\"name\":\"Le d\u00e9pistage ne r\u00e9duit pas la mortalit\u00e9 due au m\u00e9lanome cutan\u00e9 - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2026\/06\/Le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome.jpeg\",\"datePublished\":\"2026-06-21T16:10:44+00:00\",\"dateModified\":\"2026-06-21T16:10:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2026\/06\/Le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome.jpeg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2026\/06\/Le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome.jpeg\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le d\u00e9pistage ne r\u00e9duit pas la mortalit\u00e9 due au m\u00e9lanome cutan\u00e9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/6affb9c7fc596daaea315c8c28318135\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le d\u00e9pistage ne r\u00e9duit pas la mortalit\u00e9 due au m\u00e9lanome cutan\u00e9 - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/","og_locale":"fr_FR","og_type":"article","og_title":"Le d\u00e9pistage ne r\u00e9duit pas la mortalit\u00e9 due au m\u00e9lanome cutan\u00e9 - RVH-Synergie.org","og_description":"\u00c0 partir de 35 ans, l&rsquo;assurance maladie l\u00e9gale prend en charge un examen cutan\u00e9 pr\u00e9ventif","og_url":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/","og_site_name":"RVH-Synergie","article_published_time":"2026-06-21T16:10:44+00:00","article_modified_time":"2026-06-21T16:10:45+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2026\/06\/Le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome.jpeg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/6affb9c7fc596daaea315c8c28318135"},"headline":"Le d\u00e9pistage ne r\u00e9duit pas la mortalit\u00e9 due au m\u00e9lanome cutan\u00e9","datePublished":"2026-06-21T16:10:44+00:00","dateModified":"2026-06-21T16:10:45+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/"},"wordCount":1282,"commentCount":0,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2026\/06\/Le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome.jpeg","keywords":["cutan\u00e9","d\u00e9pistage","due","m\u00e9lanome","mortalit\u00e9","pas","r\u00e9duit"],"articleSection":["Les maladies"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/","url":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/","name":"Le d\u00e9pistage ne r\u00e9duit pas la mortalit\u00e9 due au m\u00e9lanome cutan\u00e9 - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2026\/06\/Le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome.jpeg","datePublished":"2026-06-21T16:10:44+00:00","dateModified":"2026-06-21T16:10:45+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2026\/06\/Le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome.jpeg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2026\/06\/Le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome.jpeg","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/le-depistage-ne-reduit-pas-la-mortalite-due-au-melanome-cutane\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"Le d\u00e9pistage ne r\u00e9duit pas la mortalit\u00e9 due au m\u00e9lanome cutan\u00e9"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/6affb9c7fc596daaea315c8c28318135","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/17558","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=17558"}],"version-history":[{"count":1,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/17558\/revisions"}],"predecessor-version":[{"id":17560,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/17558\/revisions\/17560"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/17559"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=17558"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=17558"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=17558"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}